Clinical Trial Update: A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update announcing the termination of a Phase 1/2 study evaluating Fruquintinib in combination with Tislelizumab in adults with advanced solid t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Endometrial Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Hutchmed | Conditions: Triple Negative Breast Cancer, Endometrial Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-07-14